Clinical trials
Completed Retinal Vein Occlusion trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 3 |
| Chengdu Kanghong Biotech Co., Ltd. | 2 |
| Hoffmann-La Roche | 2 |
| Zhongnan Hospital | 2 |
| Allergan | 1 |
| Bayer | 1 |
| Beijing Hospital | 1 |
| Visionary Intelligence Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 16 |
| Macular Edema | 9 |
| Diabetic Retinopathy | 3 |
| Vision Disorders | 2 |
| Central Serous Chorioretinopathy | 1 |
| Diabetes Mellitus | 1 |
| Epiretinal Membrane | 1 |
| Glaucoma, Neovascular | 1 |
| Macular Degeneration | 1 |
| Ocular Hypertension | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.